 BenefitsPRO is the leading source of employee benefits news, trends, opinions, and sales tips for benefit brokers, managers, and retirement advisors Biosimilars and transparency can tame employers' $80,000-per-year drug bills
2025-09-29 16:25 UTC by BenefitsProSharon Fausthttps://feeds.feedblitz.com/-/925535246/0/benefitspro.jpgCost-Containment/Health Care Reform/Cost-Containment/Employer-Paid/Voluntary Benefits/Employee-Paid/Core and Group Health/CommentaryDisease-modifying antirheumatic drugs like Humira and Stelara now have more affordable competitors. 
Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative. |
